Alefacept in the treatment of psoriatic nail disease: a proof of concept study.

Article Details

Citation
Copy to clipboard

Parrish CA, Sobera JO, Robbins CM, Cantrell WC, Desmond RA, Elewski BE

Alefacept in the treatment of psoriatic nail disease: a proof of concept study.

J Drugs Dermatol. 2006 Apr;5(4):339-40.

PubMed ID
16673801 [ View in PubMed
]
Abstract

Nail psoriasis can be debilitating and as therapeutic options are limited, it can be notoriously difficult to treat. As there are many new medications currently undergoing clinical trials in psoriasis, questions have arisen concerning the effectiveness of these new therapies with regard to psoriatic nail disease. We present the results of a prospective, open-label, proof of concept study to determine the efficacy and safety of alefacept in subjects with moderate to severe nail psoriasis.

DrugBank Data that Cites this Article

Drugs